Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 23 filings·Updated 13 Aug 2026
Showing 10 of 23 filings.
13 Aug 20261 filing
Company UpdateNewspaper Publication

Please find attached Copies of Newpaper Publication of the Extract of the Revised Audited Financial Results for the Quarter & year ended March 31, 2026, and Unaudited Financial results ....

Filed 12:38View Source
12 Aug 20261 filing
Corp. ActionBook Closure

National Peroxide schedules 6th AGM on Sept 29, 2026; book closure and dividend details

AGM, book closure and dividend

  • AGM to be held on September 29, 2026 via video conference/AV.
  • Book closure for AGM and final dividend from September 23 to September 29, 2026 (inclusive).
  • Record date for AGM and final dividend fixed at September 22, 2026.
  • Final dividend recommended at 70% (₹7 per equity share of ₹10), subject to member approval.
  • Dividend payment, if declared, will be made within applicable statutory timelines.
  • Security affected: equity shares of ₹10 face value.
Filed 13:27View Source
9 Aug 20261 filing
Board Meeting

National Peroxide Board to consider revised March 2026 results and June 2026 unaudited results on Aug 12, 2026.

Meeting Details

  • Board meeting scheduled for August 12, 2026; time and venue not disclosed.

Key Agenda Items

  • Revised Audited Financial Results for quarter and year ended March 31, 2026; Revised Audited Financial Statements.
  • Un-audited Financial Results for the quarter ended June 30, 2026.
Filed 17:46View Source
15 Jul 20261 filing
Company UpdateChange in Management

National Peroxide CIO Rajeev Pradhan resigns effective 15 July 2026 for personal reasons

CIO resignation

  • Resignation of Rajeev Pradhan as Chief Information Officer, effective 15 July 2026, due to personal reasons.
Filed 18:11View Source
7 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate confirms dematerialisation processing and listing for quarter ended 30 June 2026

Dematerialisation status

  • Registrar confirmed processing of all dematerialisation requests for quarter ended 30 June 2026.
  • Securities dematerialised during the period have been listed on the stock exchanges where the earlier securities are listed.
  • Certificates received for dematerialisation were mutilated and cancelled; depository name substituted as registered owner within prescribed timelines.
Filed 17:40View Source
26 Mar 20261 filing
Insider Trading / SASTClosure of Trading Window

The Company has informed the Stock Exchange about the closure of Trading window.

Filed 13:49View Source
6 Feb 20261 filing
Company UpdateNewspaper Publication

Newspaper Advertisement for the unaudited financial results of the company for the Quarter and Nine months ended December 31, 2025.

Filed 13:56View Source
5 Feb 20263 filings
Company UpdateAppointment of Company Secretary / Compliance Officer

The Company has informed the Exchange about appointment of Company Secretary and Compliance Officer of the Company.

Filed 20:35View Source
ResultFinancial Results

National Peroxide Ltd - 544205 - Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2025

Financial Performance 📊

  • Q3 FY26 revenue from operations: ₹6,908.70 lakhs; 9M FY26 revenue: ₹20,402.85 lakhs.
  • Q3 FY26 profit before tax: ₹63.44 lakhs; 9M FY26 profit before tax: ₹377.28 lakhs.
  • Q3 FY26 profit after tax: ₹38.59 lakhs; 9M FY26 profit after tax: ₹424.37 lakhs.
  • Q3 FY26 basic EPS: ₹0.67; 9M FY26 basic EPS: ₹7.38.
  • Total expenses for 9M FY26: ₹21,191.42 lakhs; raw materials cost: ₹10,547.55 lakhs.
  • Exceptional item of ₹58.15 lakhs recognized due to actuarial valuation of past service costs.

Corporate Updates 🗓️

  • Mr. Akshay Satasiya appointed Company Secretary & Compliance Officer and KMP effective March 9, 2026.

Business Model & Segments 🏭

  • Operates in a single segment: manufacturing of Hydrogen Peroxide.

Audit & Compliance 🧾

  • Statutory auditors issued an unmodified limited review report on Q3 and 9M FY26 results.
Filed 20:32View Source
Board MeetingOutcome of Board Meeting

National Peroxide Ltd - 544205 - Board Meeting Outcome for Approval Of Un-Audited Financial Results For The Quarter And Nine Months Ended December 31, 2025

Financial Performance

  • Board approved unaudited standalone financial results for quarter and nine months ended December 31, 2025.
  • Profit before tax for nine months ended December 31, 2025 was ₹573.97 lakhs; profit after tax was ₹424.37 lakhs.
  • Exceptional item of ₹58.15 lakhs recognized due to actuarial valuation of past service costs under new Social Security Code.
  • Statutory auditors issued an unmodified limited review report on these unaudited financial results.

Appointments

  • Mr. Akshay Satasiya appointed Company Secretary, Compliance Officer, and Key Managerial Personnel effective March 9, 2026.
  • Mr. Satasiya authorized to determine materiality of events/transactions for stock exchange disclosures under Regulation 30(5).
Filed 20:25View Source
Showing 10 of 23 filings